G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) (N-Term) Peptide
Aperçu rapide pour G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) (N-Term) Peptide (ABIN8101211)
Antigène
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- KIAA1333 Peptide - N-terminal region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-KIAA1333 antibody ( ARP43228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
-
Sujet
-
Background Information: KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
Alternative Symbols: FLJ20333, G2E3, PHF7B, KIAA1333
-
Poids moléculaire
- 80kDa
-
ID gène
- 55632
-
NCBI Accession
- NP_060239
-
UniProt
- Q7L622
Antigène
-